The University of Birmingham has launched a trial which could lead to a ground-breaking new way of treating people with two types of chronic liver disease. Up to 56 patients are being recruited to take part in the MERLIN trial, which will investigate the safety and efficacy of a new cellular immunotherapy in patients with […]
If you are not happy with the results below please do another search
Would you like to read a capsule summary of what the MERLIN project has accomplished? Well, please download and share the MERLIN Final Flyer here.
- RT @AutoImmuneLiver: Stay conmected with patient support groups @PSCSupportUK @PSCPartners to keep up with progress. Cure is a challenge bu… Time ago 13 Days via Twitter Web Client
- RT @nephstrom: JUST OUT! A new #OpenAccess @nephstrom publication in @FrontImmunol from our partners at @Istituto di Ricerche Farmacologich… Time ago 13 Days via Twitter Web Client
- RT @EUPHORIAH2020: Noninvasive modalities MRI, PET identify intestinal inflammation, longitudinally monitor disease status or detect change… Time ago 23 Days via Twitter for iPhone
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.